Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 6/20 | 0.62 |
| ▸ | NPC1 | O15118 | 5/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2171585 | 1.00 | CCR4 (0.62) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL262399 | 1.00 | CCR4 (0.62) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL2173513 | 0.90 | CCR4 (0.58) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL27818134 | 0.90 | CCR4 (0.58) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL262464 | 0.89 | FFAR2 (0.51) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL1820481 | 0.89 | FFAR2 (0.51) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL2185845 | 0.89 | FFAR2 (0.51) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL27818106 | 0.88 | FFAR2 (0.50) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL2185593 | 0.88 | FFAR2 (0.50) | CCR4NPC1RAB9AALDH1A1GAA | |
| SCHEMBL15402349 | 0.85 | CCR4 (0.62) | CCR4NPC1RAB9AALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346841-B1 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPÉ S P A (IT) | 2015-01-14 | — | — | EP | claimed |
| US-20110207785-A1 | 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them | DOMPE S.P.A. (IT) | 2011-08-25 | — | — | US | claimed |
| EP-2346841-A2 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompe S.p.A. (IT) | 2011-07-27 | — | — | EP | claimed |
| WO-2010031835-A2 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE' S.P.A. (IT) | 2010-03-25 | — | — | WO | claimed |
| EP-2166006-A1 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | Dompe' S.P.A. (IT) | 2010-03-24 | — | — | EP | claimed |
| EP-2346841-B1 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPÉ S P A (IT) | 2015-01-14 | — | — | EP | disclosed |
| EP-2346841-B1 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPÉ S P A (IT) | 2015-01-14 | — | — | EP | disclosed |
| US-8624036-B2 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | DOMPE S.P.A. (IT) | 2014-01-07 | — | — | US | disclosed |
| US-8624036-B2 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | DOMPE S.P.A. (IT) | 2014-01-07 | — | — | US | disclosed |
| US-8624036-B2 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | DOMPE S.P.A. (IT) | 2014-01-07 | — | — | US | disclosed |
| US-20110207785-A1 | 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them | DOMPE S.P.A. (IT) | 2011-08-25 | — | — | US | disclosed |
| US-20110207785-A1 | 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them | DOMPE S.P.A. (IT) | 2011-08-25 | — | — | US | disclosed |
| US-20110207785-A1 | 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them | DOMPE S.P.A. (IT) | 2011-08-25 | — | — | US | disclosed |
| EP-2346841-A2 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompe S.p.A. (IT) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010031835-A2 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE' S.P.A. (IT) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010031835-A2 | 2-ARYL-PROPIONIC ACIDS AND DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE' S.P.A. (IT) | 2010-03-25 | — | — | WO | disclosed |
| EP-2166006-A1 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | Dompe' S.P.A. (IT) | 2010-03-24 | — | — | EP | disclosed |
| EP-2166006-A1 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | Dompe' S.P.A. (IT) | 2010-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207785-A1 | 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them | CXCR3, F2RL1, FPR2 | CCR4 386/4885NPC1 1922/4885RAB9A 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.